Antiparkinsonian dopamine agonists: a review of the pharmacokinetics and neuropharmacology in animals and humans (Q36533717)

14 August 2017

1 reference

title

Antiparkinsonian dopamine agonists: a review of the pharmacokinetics and neuropharmacology in animals and humans (English)

1 reference

14 August 2017

1 reference

1 reference

28 October 2022

1 reference

H. Wachtel

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1683537

28 October 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1683537

28 October 2022

publication date

1 January 1991

1 reference

full work available at URL

14 August 2017

http://link.springer.com/content/pdf/10.1007/BF02259537.pdf

file format

Portable Document Format

1 reference

http://link.springer.com/article/10.1007/BF02259537/fulltext.html

28 October 2022

1 reference

http://link.springer.com/content/pdf/10.1007/BF02259537

28 October 2022

1 reference

Journal of neural transmission. Parkinson's disease and dementia section

28 October 2022

published in

1 reference

14 August 2017

3

1 reference

14 August 2017

3

1 reference

14 August 2017

151-201

1 reference

https://scigraph.springernature.com/pub.10.1007/bf02259537

14 August 2017

0 references

cites work

Evidence for dopamine receptor stimulation by apomorphine.

1 reference

https://api.crossref.org/works/10.1007%2FBF02259537

Selectivity of some ergot derivatives for 5-HT1 and 5-HT2 receptors of rat cerebral cortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02259537

Effect of ergot drugs on central catecholamine neurons: evidence for a stimulation of central dopamine neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02259537

Pergolide elevation of MHPG sulphate concentration in rat hypothalamus blocked by spiperone and mimicked by other dopamine agonists.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02259537

Effect of pergolide on MOPEG sulphate levels in rat brain regions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02259537

Inhibitory role of D-1 dopamine receptors for the jerks induced by B-HT 920 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02259537

Differential anatomical location of [3H]-N,n-propylnorapomorphine and [3H]-spiperone binding sites in the striatum and substantia nigra of the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02259537

Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02259537

Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02259537

Concentration-response relations for apomorphine effects on heart rate in conscious rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02259537

Letter: Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02259537

Suppression of prolactin by dopamine agonists in schizophrenics and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF02259537

International journal of clinical pharmacology, therapy and toxicology

21 January 2018

1

15

106

WH Aellig

1977

1 reference

Advances in biochemical psychopharmacology

28 October 2022

2

16

433

GK Aghajanian

1977

1 reference

Picomolar affinity of 125I-SCH 23982 for D1 receptors in brain demonstrated with digital subtraction autoradiography.

28 October 2022

3

1 reference

Dopamine receptor subtypes: beyond the D1/D2 classification

28 October 2022

5

1 reference

Inhibition of SKF 38393- and pergolide-induced circling in rats with unilateral 6-OHDA lesion is correlated to dopamine D-1 and D-2 receptor affinities in vitro

28 October 2022

7

1 reference

Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats

28 October 2022

8

1 reference

Stimulatory action of lisuride on dopamine-sensitive adenylate cyclase in the rat striatal homogenate

28 October 2022

9

1 reference

Opposing actions of D-1 and D-2 dopamine receptor-mediated alterations of adenosine-3',5'-cyclic monophosphate (cyclic AMP) formation during the amphetamine-induced release of endogenous dopamine in vitro

28 October 2022

10

1 reference

Dopaminergic mechanisms in hemiparkinsonian monkeys

28 October 2022

11

1 reference

D-1 dopamine receptor changes after striatal quinolinic acid lesion

28 October 2022

12

1 reference

Effects of extinction, pimozide, SCH 23390, and metoclopramide on food-rewarded operant responding of rats.

28 October 2022

14

1 reference

Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations

28 October 2022

15

1 reference

Inhibition by dopamine of (Na(+)+K+)ATPase activity in neostriatal neurons through D1 and D2 dopamine receptor synergism

28 October 2022

16

1 reference

Disposition of apomorphine in rat brain areas: relationship to stereotypy.

28 October 2022

17

1 reference

Comparative study of central dopaminergic properties of RU 29717 (N-propyl-9-oxaergoline) and pergolide

28 October 2022

18

1 reference

28 October 2022

Pharmacological Reviews

19

5

193

HL Borison

1953

1 reference

Selective D-1 dopamine receptor agonist treatment of Parkinson's disease

28 October 2022

20

1 reference

28 October 2022

Molecular Pharmacology

21

28

515

M Bräutigam

1985

1 reference

A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine

28 October 2022

23

1 reference

Treatment of parkinsonism with bromocriptine.

28 October 2022

24

1 reference

Oral bioavailability of apomorphine in the rat with a portacaval venous anastomosis

28 October 2022

25

1 reference

Autoradiographic localization of dopamine D 1 and D 2 receptors in the brain of several mammalian species

28 October 2022

26

1 reference

The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice

28 October 2022

27

1 reference

Effects of D1 and D2 antagonists on basal and apomorphine decreased body temperature in mice and rats

28 October 2022

29

1 reference

Classification of drugs according to receptor binding profiles

28 October 2022

31

1 reference

[3H]205-501, a non-catechol dopaminergic agonist, labels selectively and with high affinity dopamine D2 receptors

28 October 2022

32

1 reference

Absence of D1 dopamine receptors that stimulate prolactin release in the rat pituitary

28 October 2022

33

1 reference

Increase in rat striatal acetylcholine content by bromocriptine: evidence for an indirect dopaminergic action

28 October 2022

34

1 reference

28 October 2022

36

1 reference

Characteristics of 3H-cis-flupenthixol binding to calf brain membranes

28 October 2022

38

1 reference

Induction of mounting behaviour in female and male rats by lisuride

28 October 2022

39

1 reference

Differential effect of food on kinetics of bromocriptine in a modified release capsule and a conventional formulation

28 October 2022

40

1 reference

The effects of selective dopamine receptor agonists and antagonists on body temperature in rats

28 October 2022

41

1 reference

Two novel prolactin release-inhibiting 8α-amino-ergolines

28 October 2022

42

1 reference

Pharmacodynamic profile of CQP 201-403, a novel 8 alpha-amino-ergoline.

28 October 2022

43

1 reference

Single K+ channels activated by D2 dopamine receptors in acutely dissociated neurons from rat corpus striatum

28 October 2022

46

1 reference

Tyrosine hydroxylase-immunoreactive boutons in synaptic contact with identified striatonigral neurons, with particular reference to dendritic spines

28 October 2022

47

1 reference

Effects of (8β)-8-[(Methylthio)methyl]-6-propylergoline on dopaminergic function and brain dopamine turnover in rats

28 October 2022

48

1 reference

Effect of chronic treatment of MPTP monkeys with dopamine D-1 and/or D-2 receptor agonists

28 October 2022

52

1 reference

Peripheral pharmacokinetics of apomorphine in humans

28 October 2022

53

1 reference

Release of dopamine from dendrites in rat substantia nigra

28 October 2022

54

1 reference

Aphrodisiac Effect of p-Chlorophenylalanine

28 October 2022

55

1 reference

Striatal phosphoproteins in Parkinson disease and progressive supranuclear palsy

28 October 2022

56

1 reference

Activation of NMDA receptors induces dephosphorylation of DARPP-32 in rat striatal slices

28 October 2022

59

1 reference

28 October 2022

Molecular Pharmacology

60

21

114

DR Haubrich

1982

1 reference

Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in mice

28 October 2022

63

1 reference

Prolactin-lowering effect of low doses of lisuride in man

28 October 2022

64

1 reference

The pharmacokinetics and biotransformation of 14C-lisuride hydrogen maleate in rhesus monkey and in man

28 October 2022

65

1 reference

Radioimmunoassay of plasma lisuride in man following intravenous and oral administration of lisuride hydrogen maleate; effect on plasma prolactin level

28 October 2022

66

1 reference

The pharmacokinetics of lisuride hydrogen maleate in rat, rabbit and rhesus monkey

28 October 2022

67

1 reference

Influence of chlorpromazine and promethazine on vomiting induced with apomorphine in man

28 October 2022

69

1 reference

Cholinergic synaptic input to different parts of spiny striatonigral neurons in the rat.

28 October 2022

70

1 reference

Bromocriptine-induced locomotor stimulation in mice is modulated by dopamine D-1 receptors

28 October 2022

71

1 reference

Biochemical and behavioral evaluation of pergolide as a dopamine agonist in the rat brain

28 October 2022

72

1 reference

The dopamine agonist bromocriptine induces hypotension by venous and arteriolar dilation.

28 October 2022

73

1 reference

Quantitative autoradiography of dopamine D2 sites in rat caudate-putamen: localization to intrinsic neurons and not to neocortical afferents

28 October 2022

75

1 reference

Biological disposition of apomorphine. IV. Isolation and characterization of "bound" apomorphine

28 October 2022

77

1 reference

Multiple receptors for dopamine

28 October 2022

78

1 reference

Dopamine-sensitive adenylate cyclase in caudate nucleus of rat brain, and its similarity to the "dopamine receptor".

28 October 2022

79

1 reference

Effect of lisuride and other ergot derivatives on monoaminergic mechanisms in rat brain

28 October 2022

80

1 reference

Specific inhibition of dopamine D-1-mediated cyclic AMP formation by dopamine D-2, muscarinic cholinergic, and opiate receptor stimulation in rat striatal slices.

28 October 2022

83

1 reference

Zeitschrift fur Kreislaufforschung

28 October 2022

86

58

210

H Konzett

1969

1 reference

Dopamine release in substantia nigra?

28 October 2022

87

1 reference

Dopamine D-1 but not D-2 receptor stimulation of the dorsal striatum potentiates apomorphine-induced jaw movements in rats.

28 October 2022

88

1 reference

Glutamate decarboxylase-like immunoreactive neurons in the rat caudate putamen

28 October 2022

89

1 reference

Cholinergic-dopaminergic interaction in the striatum: The effect of 6-hydroxydopamine or pimozide treatment on the increased striatal acetylcholine levels induced by apomorphine, piribedil andD-amphetamine

28 October 2022

90

1 reference

The New England Journal of Medicine

28 October 2022

91

309

310

JW Langston

1983

1 reference

The striatal cholinergic interneuron: synaptic target of dopaminergic terminals?

28 October 2022

92

1 reference

Pharmacologic Effects in Man of a Potent, Long-Acting Dopamine Receptor Agonist

28 October 2022

93

1 reference

Permissive role of D-1 receptor stimulation by endogenous dopamine for the expression of postsynaptic D-2-mediated behavioural responses. Yawning in rats

28 October 2022

94

1 reference

Expression of striatal D1 dopamine receptors coupled to inositol phosphate production and Ca2+ mobilization in Xenopus oocytes

28 October 2022

96

1 reference

Effects of different dopaminergic antagonists on bromocriptine-induced inhibition of norepinephrine release

28 October 2022

97

1 reference

Effects of dopamine and noradrenaline on Ca channels of cultured sensory and sympathetic neurons of chick.

28 October 2022

99

1 reference

The effect of bromocriptine on rat striatal adenylate cyclase and rat brain monoamine metabolism

28 October 2022

102

1 reference

Fate and disposition of bromocriptine in animals and man. I: structure elucidation of the metabolites

28 October 2022

103

1 reference

Fate and disposition of bromocriptine in animals and man. II: Absorption, elimination and metabolism

28 October 2022

105

1 reference

The selectivity of some ergot derivatives for α1 and α2-adrenoceptors of rat cerebral cortex

28 October 2022

106

1 reference

O-methylation of apomorphine and the metabolic prolongation of apomorphine-induced stereotyped behaviour

28 October 2022

107

1 reference

Pharmacological characterization in the rat of grooming and other behavioural responses to the D1 dopamine receptor agonist R-SK&F 38393

28 October 2022

108

1 reference

Production of climbing behaviour in mice requires both D1 and D2 receptor activation

28 October 2022

109

1 reference

Autoradiographic localization of neuroleptic and dopamine receptors in the caudate-putamen and substantia nigra: effects of lesions

28 October 2022

112

1 reference

The use of kainic acid in the localization of enzymes in the substantia nigra

28 October 2022

113

1 reference

Reduction of the rewarding effect of brain stimulation by a blockade of dopamine D1 receptor with SCH 23390.

28 October 2022

114

1 reference

The apomorphine antagonism test in dogs. Experimental evidence and critical considerations on specific methodological criteria

28 October 2022

115

1 reference

Pharmacological characterization of D1 and D2 dopamine receptors in rat limbocortical areas. I. Frontal cortex.

28 October 2022

116

1 reference

The dopamine D2 agonist LY 141865, but not the D1 agonist SKF 38393, reverses parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset

28 October 2022

117

1 reference

Lisuride infusion pump: a device for the treatment of motor fluctuations in Parkinson's disease

28 October 2022

118

1 reference

28 October 2022

Molecular Pharmacology

119

28

138

P Onali

1985

1 reference

Dopamine D2 receptor stimulation decreases the inositol trisphosphate level of rat striatal slices

28 October 2022

123

1 reference

Stimulation of pre- and postsynaptic dopamine receptors by an ergoline and by a partial ergoline

28 October 2022

124

1 reference

Response of central monoaminergic neurons to lisuride: Comparison with LSD

28 October 2022

127

1 reference

Selective dopamine D2 receptor reduction enhances a D1-mediated oral dyskinesia in rats.

28 October 2022

128

1 reference

Forebrain pathways of reward in Rattus norvegicus.

28 October 2022

130

1 reference

Physiologic disposition of pergolide

28 October 2022

131

1 reference

Bromocriptine and lisuride stimulate the accumulation of cyclic AMP in intact slices but not in homogenates of rat neostriatum

28 October 2022

132

1 reference

Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat.

28 October 2022

133

1 reference

Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats

28 October 2022

134

1 reference

Advances in biochemical psychopharmacology

28 October 2022

135

23

125

HF Schran

1980

1 reference

Pharmacokinetics and pharmacodynamics of bromocriptine in the rat.

28 October 2022

136

1 reference

28 October 2022

Pharmacological Reviews

139

32

229

P Seeman

1980

1 reference

The central effects of a novel dopamine agonist

28 October 2022

141

1 reference

Conversion of apocodeine to apomorphine and norapomorphine in rats.

28 October 2022

142

1 reference

Apomorphine: bioavailability and effect on stereotyped cage climbing in mice

28 October 2022

143

1 reference

Interactions of apomorphine with serum and tissue proteins.

28 October 2022

144

1 reference

Molecular cloning and characterization of a novel dopamine receptor (D3) as a target for neuroleptics

28 October 2022

146

1 reference

Effects of neuroleptic drugs on the inhibition of exploratory behaviour induced by a low dose of apomorphine: implications for the identity of dopamine receptors.

28 October 2022

147

1 reference

Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?

28 October 2022

148

1 reference

Detection of dopamine receptors in the area postrema

28 October 2022

149

1 reference

Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of γ-aminobutyric acid, glutamate or serotonin

28 October 2022

150

1 reference

Opposing roles for D-1 and D-2 dopamine receptors in efflux of cyclic AMP from rat neostriatum

28 October 2022

151

1 reference

Autoreceptors mediate the inhibition of dopamine synthesis by bromocriptine and lisuride in rats.

28 October 2022

154

1 reference

Drug Metabolism and Disposition

28 October 2022

155

9

108

T Toda

1981

1 reference

Localization of D-2 dopamine receptors to intrinsic striatal neurones by quantitative autoradiography.

28 October 2022

156

1 reference

Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists

28 October 2022

157

1 reference

Dopamine control of seizure propagation: intranigral dopamine D1 agonist SKF-38393 enhances susceptibility to seizures

28 October 2022

158

1 reference

Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system.

28 October 2022

159

1 reference

Neurochemical and Neuropharmacological Investigations with Four Ergot Derivatives: Bromocriptine, Dihydroergotoxine, CF 25-397 and CM 29-712

28 October 2022

160

1 reference

Dopamine D2Receptors Attenuate Phosphatidylisitol 4,5-Bisphosphate in Synaptosomal Membranes from Rat Neostriatum

28 October 2022

161

1 reference

D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems

28 October 2022

163

1 reference

Drugs acting on brain dopamine receptors: a conceptual re-evaluation five years after the first selective D-1 antagonist

28 October 2022

164

1 reference

DARPP-32, a dopamine- and adenosine 3':5'-monophosphate-regulated phosphoprotein enriched in dopamine-innervated brain regions. I. Regional and cellular distribution in the rat brain

28 October 2022

165

1 reference

D-1 type of dopamine autoreceptors are not involved in the regulation of dopamine synthesis in the striatum

28 October 2022

166

1 reference

28 October 2022

Pharmacological Reviews

167

37

165

JL Willems

1985

1 reference

LY141865, a D2-dopamine agonist, increases acetylcholine concentration in rat corpus striatum

28 October 2022

168

1 reference

28 October 2022

Federation Proceedings

169

37

741

SH Wong

1978

1 reference

28 October 2022

Identifiers

DOI

10.1007/BF02259537

1 reference

14 August 2017

1 reference